Cardiac Applications of CRISPR/AAV-Mediated Precise Genome Editing
Author Information
Author(s): Zheng Yanjiang, Mayourian Joshua, King Justin S., Li Yifei, Bezzerides Vassilios J., Pu William T., VanDusen Nathan J.
Primary Institution: Cold Spring Harbor Laboratory
Hypothesis
We hypothesized that we could assay the activity of precisely integrated cis-regulatory elements in vivo within cardiomyocytes.
Conclusion
The study demonstrates that CASAAV-HDR can be used for precise genome editing in cardiomyocytes, enabling disease modeling and functional genomics.
Supporting Evidence
- CASAAV-HDR can create precise edits in vivo within both mitotic and postmitotic cardiomyocytes.
- Using CASAAV-HDR, two different mutations in the Ttn gene were created to study their effects on cardiomyopathy.
- PLN-R14Del mutation was efficiently generated in vivo within postnatal cardiomyocytes via CASAAV-HDR.
Takeaway
This study shows how scientists can use a special tool called CASAAV-HDR to make precise changes in the genes of heart cells, which helps them understand heart diseases better.
Methodology
The study used CASAAV-HDR to create precise genome edits in mouse cardiomyocytes for disease modeling and functional genomics.
Limitations
HDR efficiency varies by target locus, and the technique is best used for strongly expressed genes.
Statistical Information
P-Value
0.0007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website